Search results - Portal of Medical Data Models (MDM-Portal)

Filter search results

Keywords

Alzheimer Disease ×

Show more Keywords

Table of contents

Select data models

Selected data models

You must log in to select data models for download or further analysis.

245 Search results.

Eligibility Alzheimer's Disease NCT02485730

- 11/18/21 - 1 form, 2 itemgroups, 9 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Early Identification of Markers in Alzheimer's Families / ALFA; ODM derived from: https://clinicaltrials.gov/show/NCT02485730

Eligibility Alzheimer Disease NCT01255046

- 11/18/21 - 1 form, 2 itemgroups, 15 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Study of STA-1 as an Add-on Treatment to Donepezil; ODM derived from: https://clinicaltrials.gov/show/NCT01255046

Eligibility Alzheimer's Disease NCT00009217

- 9/27/21 - 1 form, 2 itemgroups, 13 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Treatment of Behavioral Symptoms in Alzheimer's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00009217

DELCODE: DZNE – Longitudinal Cognitive Impairment and Dementia Study - Diagnosis criteria Amyotrophic lateral sclerosis (ALS) (Diagnosekriterien Amyotrophe Lateralsklerose (ALS))

- 9/20/21 - 1 form, 12 itemgroups, 34 items, 1 language

Itemgroups: Administrative Data,Amyotrophic lateral sclerosis (ALS),Diagnostic criteria and motor subtypes, classical ALS,ALS exclusion criteria,Diagnosis facilitation,ALS occurrence,ALS (not impaired) without cognitive impairment,ALS (cognitive impaired),ALS (behaviourally impaired),ALS (cognitively and behaviourally impaired),ALS‐FTD,ALS (without cognitive impairment, genetic risk for FTD)

DELCODE is conducted by DZNE, the German Center for Neurodegenerative Diseases within the Helmholtz Association. The following information was taken from https://www.dzne.de/en/research/studies/clinical-studies/delcode/. Background and aims: One of the important aims of research into Alzheimer's is to find ways of detecting the disease early – if at all possible, as soon as the first minor symptoms appear, or even before any symptoms at all have appeared. Such detection capabilities are the necessary basis for development of therapies that can be applied at such early stages in the disease. Recent research indicates that such therapies could be more effective than therapies initiated during the disease's later stages. Over a period of several years, the DELCODE study is studying persons in early stages of the disease, along with various risk groups. The research is aimed at the development of procedures for characterizing early stages of the disease, at improving prediction of the course of the disease and at identifying new markers for early diagnosis of Alzheimer's-related dementia. Overview: DELCODE is set up to run for an initial period of three years, and to include a total of 1,000 study participants, who will be examined on a yearly basis. The group of participants will include persons with no complaints (healthy control subjects), patients with slight memory impairment or mild dementia and first-degree relatives of patients with diagnosed Alzheimer's disease. The minimum age for participants is 60. Course of the study: The examinations in the framework of the study will include a comprehensive interview carried out by a study investigator, a detailed neuropsychological examination (testing of memory functions and other areas of cognitive performance), a blood test and a cranial MRI scan. Optionally, subject to the study participant's consent in each case, a lumbar puncture (collection of cerebrospinal fluid) will be carried out." For more information (e.g. principle investigator and study coordination), please visit the above link or https://www.dzne.de. This document contains the Diagnosis criteria Amyotrophic lateral sclerosis (ALS) form. It has to be filled in if an ALS is diagnosed. Note: If there is a motor neuron disease, fill in the motor neuron disease assessment!

Eligibility Caregivers NCT00558402

- 9/20/21 - 1 form, 2 itemgroups, 10 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Meditation or Education for Alzheimer Caregivers; ODM derived from: https://clinicaltrials.gov/show/NCT00558402

Study of Alzheimer's Disease in Down Syndrome NCT02141971 - Eligibility

- 9/20/21 - 1 form, 2 itemgroups, 11 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Non-randomized natural history study involving 12 subjects with Down Syndrome, who are aged 30-60 years old. This study will observe 3 different groups: four non-demented subjects between ages 30-40 years old, four non-demented subjects between ages 40-50 years old, and four demented subjects 50-60 years old. ODM derived from: https://clinicaltrials.gov/show/NCT02141971

Eligibility Alzheimer Disease NCT00322036

- 9/20/21 - 1 form, 2 itemgroups, 13 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's; ODM derived from: https://clinicaltrials.gov/show/NCT00322036

Eligibility Alzheimer Disease NCT00253214

- 9/20/21 - 1 form, 2 itemgroups, 9 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation; ODM derived from: https://clinicaltrials.gov/show/NCT00253214

Eligibility Alzheimer Disease NCT00088673

- 9/20/21 - 1 form, 2 itemgroups, 15 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Evaluation of 3APS in Patients With Mild to Moderate Alzheimer’s Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00088673

Eligibility Alzheimer Disease NCT00062569

- 9/20/21 - 1 form, 1 itemgroup, 15 items, 1 language

Itemgroup: Criteria

Bathing Persons With Alzheimer's Disease aT Home (The BATH Study); ODM derived from: https://clinicaltrials.gov/show/NCT00062569

Eligibility Alzheimer Disease NCT00979316

- 9/20/21 - 1 form, 2 itemgroups, 11 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects; ODM derived from: https://clinicaltrials.gov/show/NCT00979316

Eligibility Alzheimer Disease NCT00908492

- 9/20/21 - 1 form, 2 itemgroups, 12 items, 1 language

Itemgroups: Inclusion Criteria,Exclusion Criteria

Supporting Caregivers of Persons With Dementia: A Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT00908492

Please use this form for feedback, questions and suggestions for improvements.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.